{"symbol": "KALA", "companyName": "Kala Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.kalarx.com", "description": "Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.", "CEO": "Mark Iwicki", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}